Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antimullerian Hormone Receptor 2 Polymorphism in Blood and Granulosa Cells in Unexplained Infertility

NCT05592730 is registered in ClinicalTrials.gov with Bezmialem Vakif University as lead sponsor.

NCT NCT05592730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05592730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antimullerian Hormone Receptor 2 Polymorphism in Blood and Granulosa Cells in Unexplained Infertility
Lead sponsor
Bezmialem Vakif University
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2022
Completion date
December 1, 2023
Enrollment
96 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amh, infertility, female, ivf